| Size | Price | Stock | Qty |
|---|---|---|---|
| 100mg |
|
||
| 500mg |
|
| ADME/Pharmacokinetics |
Absorption, Distribution and Excretion
In rats, the primary route of excretion is urine. The concentration of radioactive material in urine samples is 2–4 times higher than in feces. Tissue levels of trisulfonamide and its metabolites increase with increasing dose, but no increase in radioactive material concentration was observed in any specific organ or tissue. Metabolism/Metabolites Trisulfonamide is rapidly and extensively metabolized in animals via N-demethylation, deesterification, sulfonylurea bridge hydrolysis, benzene ring hydroxylation, and/or triazine ring O-demethylation. Major metabolites in urine and feces include mesulfonamide, saccharin, and O-dimethyltriazineamine. The two main metabolic pathways are demethylation of the carbamoylmethyl group and hydrolysis of the carbamoyl ester moiety. |
|---|---|
| Toxicity/Toxicokinetics |
Toxicity Data
LC50 (Rat) > 5,000 mg/m³/4h Non-human Toxicity Values LD50 (Rats, Oral) > 5,000 mg/kg LD50 (Rabbit, Skin) > 2,000 mg/kg LC50 (Rats, Inhalation) > 5.0 mg/L Air/4 hours |
| References | |
| Additional Infomation |
Methyltriphenyluron is a colorless, non-corrosive crystal used as a herbicide. Methyltriphenyluron is the methyl ester of triphenyluron, a herbicide. It is a methoxy-1,3,5-triazine compound belonging to the N-sulfonylurea class, possessing both methyl ester and benzoate structures. Its function is similar to triphenyluron. Methyltriphenyluron is the methyl ester of the sulfonylurea herbicide triphenyluron, and is also the form of triphenyluron used in pesticides. It is used in cereal cultivation to control broadleaf weeds. Similar to other sulfonylurea herbicides, the site of action of methyltriphenyluron is acetolactate synthase (ALS), an enzyme involved in the biosynthesis of branched-chain amino acids. Sulfonylurea herbicides were discovered by DuPont in 1975 and first marketed in 1982.
|
| Molecular Formula |
C15H17N5O6S
|
|---|---|
| Molecular Weight |
395.39
|
| Exact Mass |
395.089
|
| CAS # |
101200-48-0
|
| PubChem CID |
153909
|
| Appearance |
Off-white powder
Light brown solid |
| Density |
1.4±0.1 g/cm3
|
| Boiling Point |
376.6ºC
|
| Melting Point |
141°C
|
| Flash Point |
181.6ºC
|
| Index of Refraction |
1.583
|
| LogP |
1.47
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
9
|
| Rotatable Bond Count |
6
|
| Heavy Atom Count |
27
|
| Complexity |
639
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
CC1=NC(N(C(NS(=O)(C2=CC=CC=C2C(OC)=O)=O)=O)C)=NC(OC)=N1
|
| InChi Key |
VLCQZHSMCYCDJL-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C15H17N5O6S/c1-9-16-13(18-14(17-9)26-4)20(2)15(22)19-27(23,24)11-8-6-5-7-10(11)12(21)25-3/h5-8H,1-4H3,(H,19,22)
|
| Chemical Name |
methyl 2-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-methylcarbamoyl]sulfamoyl]benzoate
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.5291 mL | 12.6457 mL | 25.2915 mL | |
| 5 mM | 0.5058 mL | 2.5291 mL | 5.0583 mL | |
| 10 mM | 0.2529 mL | 1.2646 mL | 2.5291 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
